FASIHA KANWAL to Models, Theoretical
This is a "connection" page, showing publications FASIHA KANWAL has written about Models, Theoretical.
Connection Strength
1.156
-
A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis. Hepatology. 2019 03; 69(3):1300-1305.
Score: 0.536
-
The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States. Aliment Pharmacol Ther. 2019 07; 50(1):66-74.
Score: 0.136
-
Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan. JAMA Netw Open. 2019 05 03; 2(5):e193613.
Score: 0.136
-
Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study. Hepatology. 2018 06; 67(6):2085-2095.
Score: 0.126
-
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA. Aliment Pharmacol Ther. 2018 Apr; 47(7):1023-1031.
Score: 0.125
-
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study. BMJ Open. 2019 06 11; 9(6):e026726.
Score: 0.034
-
Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy. Clin Gastroenterol Hepatol. 2019 03; 17(4):739-747.e8.
Score: 0.032
-
Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):115-122.e10.
Score: 0.030